Literature DB >> 31809836

Chemical probes for protein arginine methyltransferases.

Alice Shi Ming Li1, Fengling Li2, Mohammad S Eram2, Albina Bolotokova2, Carlo C Dela Seña2, Masoud Vedadi3.   

Abstract

Protein arginine methyltransferases (PRMTs) catalyze the transfer of methyl groups to specific arginine residues of their substrates using S-adenosylmethionine as a methyl donor, contributing to regulation of many biological processes including transcription, and DNA damage repair. Dysregulation of PRMT expression is often associated with various diseases including cancers. Different methods have been used to characterize the activities of PRMTs and determine their kinetic parameters including mass spectrometry, radiometric, and antibody-based assays. Here, we present kinetic characterization of PRMTs using a radioactivity-based assay for better comparison along with previously reported values. We also report on full characterization of PRMT9 activity with SAP145 peptide as substrate. We further review the potent, selective and cell-active PRMT inhibitors discovered in recent years to provide a better understanding of available tools to investigate the roles these proteins play in health and disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arginine methylation; Cancer; Chemical probe; PRMT

Mesh:

Substances:

Year:  2019        PMID: 31809836     DOI: 10.1016/j.ymeth.2019.11.017

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  6 in total

Review 1.  Protein arginine methylation: from enigmatic functions to therapeutic targeting.

Authors:  Qin Wu; Matthieu Schapira; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy
Journal:  Nat Rev Drug Discov       Date:  2021-03-19       Impact factor: 84.694

2.  PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As2O3 by stabilizing oncoprotein PML-RARα.

Authors:  Xinping Huang; Yongfeng Yang; Dan Zhu; Yan Zhao; Min Wei; Ke Li; Hong-Hu Zhu; Xiaofeng Zheng
Journal:  Cell Mol Life Sci       Date:  2022-05-27       Impact factor: 9.261

3.  Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5.

Authors:  Ayad A Al-Hamashi; Dongxing Chen; Youchao Deng; Guangping Dong; Rong Huang
Journal:  Acta Pharm Sin B       Date:  2020-10-16       Impact factor: 14.903

4.  Genetic evidence for partial redundancy between the arginine methyltransferases CARM1 and PRMT6.

Authors:  Donghang Cheng; Guozhen Gao; Alessandra Di Lorenzo; Sandrine Jayne; Michael O Hottiger; Stephane Richard; Mark T Bedford
Journal:  J Biol Chem       Date:  2020-10-02       Impact factor: 5.157

5.  Repurposing epigenetic inhibitors to target the Clostridioides difficile-specific DNA adenine methyltransferase and sporulation regulator CamA.

Authors:  Jujun Zhou; John R Horton; Dan Yu; Ren Ren; Robert M Blumenthal; Xing Zhang; Xiaodong Cheng
Journal:  Epigenetics       Date:  2021-09-15       Impact factor: 4.861

6.  Synthesis and Activity of Triazole-Adenosine Analogs as Protein Arginine Methyltransferase 5 Inhibitors.

Authors:  Tyler Brown; Mengtong Cao; Y George Zheng
Journal:  Molecules       Date:  2022-06-11       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.